M. E. Lippman

2.6k total citations
57 papers, 2.1k citations indexed

About

M. E. Lippman is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, M. E. Lippman has authored 57 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 23 papers in Genetics and 12 papers in Molecular Biology. Recurrent topics in M. E. Lippman's work include Estrogen and related hormone effects (20 papers), Cancer Treatment and Pharmacology (9 papers) and Cancer Cells and Metastasis (7 papers). M. E. Lippman is often cited by papers focused on Estrogen and related hormone effects (20 papers), Cancer Treatment and Pharmacology (9 papers) and Cancer Cells and Metastasis (7 papers). M. E. Lippman collaborates with scholars based in United States, Italy and Germany. M. E. Lippman's co-authors include Robert B. Dickson, Larry M. Weisenthal, Karen Huff, Eugenio Spencer, Gerhard Zugmaier, Sandra M. Swain, Anton Wellstein, Seth M. Steinberg, Elizabeth Egan and Helene S. Smith and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

M. E. Lippman

56 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. E. Lippman United States 24 998 919 599 563 240 57 2.1k
G. Daxenbichler Austria 28 727 0.7× 1.1k 1.2× 339 0.6× 479 0.9× 127 0.5× 90 2.3k
Hiroshi Sonoo Japan 26 1.3k 1.3× 820 0.9× 645 1.1× 476 0.8× 277 1.2× 123 2.3k
Shunzo Kobayashi Japan 28 1.2k 1.2× 1.1k 1.2× 786 1.3× 716 1.3× 237 1.0× 74 2.3k
Marc E. Lippman United States 13 1.0k 1.0× 792 0.9× 854 1.4× 474 0.8× 451 1.9× 16 2.2k
Björn Erikstein Norway 24 1.3k 1.3× 859 0.9× 702 1.2× 968 1.7× 176 0.7× 47 2.7k
H. Rabes Germany 28 784 0.8× 1.2k 1.3× 450 0.8× 309 0.5× 287 1.2× 115 2.5k
Sten Wingren Sweden 24 1.0k 1.0× 701 0.8× 625 1.0× 581 1.0× 443 1.8× 63 2.1k
Darrow E. Haagensen United States 28 750 0.8× 603 0.7× 420 0.7× 371 0.7× 463 1.9× 63 2.2k
David G. Cox United States 28 517 0.5× 1.2k 1.4× 634 1.1× 575 1.0× 178 0.7× 69 2.3k
Elizabeth Anderson United Kingdom 20 905 0.9× 627 0.7× 527 0.9× 1.1k 2.0× 148 0.6× 44 1.9k

Countries citing papers authored by M. E. Lippman

Since Specialization
Citations

This map shows the geographic impact of M. E. Lippman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Lippman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Lippman more than expected).

Fields of papers citing papers by M. E. Lippman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. E. Lippman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Lippman. The network helps show where M. E. Lippman may publish in the future.

Co-authorship network of co-authors of M. E. Lippman

This figure shows the co-authorship network connecting the top 25 collaborators of M. E. Lippman. A scholar is included among the top collaborators of M. E. Lippman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. E. Lippman. M. E. Lippman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giani, Claudio, Aldo Pinchera, Audrey Rasmussen, et al.. (1998). Stromal IGF-II messenger RNA in breast cancer: Relationship with progesterone receptor expressed by malignant epithelial cells. Journal of Endocrinological Investigation. 21(3). 160–165. 15 indexed citations
2.
Swain, Sandra M., Julia H. Rowland, Kevin P. Weinfurt, et al.. (1996). Intensive outpatient adjuvant therapy for breast cancer: results of dose escalation and quality of life.. Journal of Clinical Oncology. 14(5). 1565–1572. 36 indexed citations
3.
McLeskey, Sandra W., Ivan Ding, M. E. Lippman, & Florian Kern. (1994). MDA‐MB‐134乳癌細胞は線維芽細胞成長因子(FGF)受容体を過剰発現し,FGFリガンドでその増殖は抑制される. Cancer Research. 54(2). 523–530. 3 indexed citations
4.
Pérez, Caridad N., et al.. (1993). Characterization and cloning of the gp30 ligand for the erbB-2 receptor, from human breast cancer cells. 34. 97. 1 indexed citations
5.
Ojasoo, Tiiu, M. E. Lippman, Henri Rochefort, & M. Namer. (1993). Breast cancer: When tumor markers become targets for drugs. Annals of Oncology. 4(3). 195–198. 4 indexed citations
6.
Bano, Mozeena, Eric Shi, Junichi Kurebayashi, et al.. (1992). Growth factors in breast cancer: Mitogenesis to transformation. The Journal of Steroid Biochemistry and Molecular Biology. 43(1-3). 69–78. 42 indexed citations
7.
Zugmaier, Gerhard, M. E. Lippman, & Anton Wellstein. (1992). Inhibition by Pentosan Polysulfate (PPS) of Heparin-Binding Growth Factors Released From Tumor Cells and Blockage by PPS of Tumor Growth in Animals. JNCI Journal of the National Cancer Institute. 84(22). 1716–1724. 104 indexed citations
8.
Knabbe, Cornelius, et al.. (1991). Induction of Transforming Growth Factor β by the Antiestrogens Droloxifene, Tamoxifen, and Toremifene in MCF-7 Cells. American Journal of Clinical Oncology. 14. 15–20. 52 indexed citations
9.
Wellstein, Anton, Gerhard Zugmaier, Joseph A. Califano, et al.. (1991). Tumor Growth Dependent on Kaposi's Sarcoma-Derived Fibroblast Growth Factor Inhibited by Pentosan Polysulfate. JNCI Journal of the National Cancer Institute. 83(10). 716–720. 81 indexed citations
10.
Dickson, Robert B., et al.. (1990). UCLA colloquium. New insights into breast cancer: the molecular biochemical and cellular biology of breast cancer.. PubMed. 50(14). 4446–7. 5 indexed citations
11.
Valverius, Eva M., et al.. (1989). Transforming Growth Factor Alpha and its Receptor in Human Mammary Epithelial Cells: Modulation of Epidermal Growth Factor Receptor Function with Oncogenic Transformation. eScholarship (California Digital Library). 3 indexed citations
12.
Clarke, Robert, N. Brünner, Erik W. Thompson, et al.. (1989). The inter-relationships between ovarian-independent growth, tumorigenicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer. Journal of Endocrinology. 122(1). 331–340. 54 indexed citations
13.
Swain, Sandra M., M. E. Lippman, Elizabeth Egan, et al.. (1989). Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.. Journal of Clinical Oncology. 7(7). 890–899. 210 indexed citations
14.
Davidson, Nancy E. & M. E. Lippman. (1989). The role of estrogens in growth regulation of breast cancer.. PubMed. 1(1). 89–111. 45 indexed citations
15.
Clarke, Robert, N. Brünner, Benita S. Katzenellenbogen, et al.. (1989). Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo.. Proceedings of the National Academy of Sciences. 86(10). 3649–3653. 152 indexed citations
16.
Lippman, M. E., et al.. (1986). Treatment of stage IIIA/B locally advanced breast cancer (LABC) with induction chemotherapy (CT) and hormonal synchronization (HS) followed by radiation therapy (RT) with or without mastectomy. International Journal of Radiation Oncology*Biology*Physics. 12. 152–152. 1 indexed citations
17.
Monaco, Marie E., et al.. (1982). Vasopressin: Action on WRK-1 Rat Mammary Tumor Cells. JNCI Journal of the National Cancer Institute. 68(2). 267–70. 4 indexed citations
18.
Monaco, Marie E., M. E. Lippman, Richard A. Knazek, & William R. Kidwell. (1978). Vasopressin stimulation of acetate incorporation into lipids in a dimethylbenz(a)anthracene-induced rat mammary tumor cell line.. PubMed. 38(11 Pt 2). 4101–4. 24 indexed citations
19.
Lippman, M. E.. (1975). Hormone dependent human breast cancer in tissue culture. Clinical research. 23(3). 1 indexed citations
20.
Lippman, M. E., Richard A. Zager, & Henderson Es. (1972). High dose daunorubicin (NSC-83142) in the treatment of advanced acute myelogenous leukemia.. PubMed. 56(6). 755–60. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Daxenbichler Breakdown of academic impact, for papers by Hiroshi Sonoo Breakdown of academic impact, for papers by Shunzo Kobayashi Breakdown of academic impact, for papers by Marc E. Lippman Breakdown of academic impact, for papers by Björn Erikstein Breakdown of academic impact, for papers by H. Rabes Breakdown of academic impact, for papers by Sten Wingren Breakdown of academic impact, for papers by Darrow E. Haagensen Breakdown of academic impact, for papers by David G. Cox Breakdown of academic impact, for papers by Elizabeth Anderson
Rankless by CCL
2026